Work

Development and temporal validation of a quantitative DCE-MRI and serum adipokine nomogram for predicting postoperative recurrence in endometrial cancer

Year: 2026
Type: article
Abstract: Background Recurrence after surgery for endometrial cancer (EC) remains difficult to predict with clinicopathological factors alone. We developed and temporally validated a nomogram combining pelvic dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) pharmacokinetic parameters and serum adipokines for postoperative recurrence risk stratification. Methods In this retrospective cohort, 348 patients with EC treated between January 2018 and December 2022 were chronologically assigned to a training set (n = 239; 2018–2021) and a temporal validation set (n = 109; 2022). Preoperative DCE-MRI-derived volume transfer constant (Ktrans), rate constant (Kep), and extravascular extracellular volume fraction (Ve), and serum leptin, adiponectin, resistin, galectin-1, galectin-9, and visfatin were assessed. Multivariable logistic regression was performed as a separate explanatory analysis. The final nomogram used a prespecified eight-variable imaging–adipokine panel. Discrimination, calibration, and decision curve analysis were evaluated. Results Recurrence occurred in 63 (26.4%) training-set patients and 28 (25.7%) validation-set patients. Recurrent cases showed higher Kᵗʳ an ˢ (0.57 ± 0.19vs.0.41 ± 0.16 min −1 ), leptin (22.61 ± 9.38vs.16.24 ± 7.74 ng/mL) and lower adiponectin (6.72 ± 2.84vs.9.58 ± 3.36 μg/mL) significantly (all P < 0.001). LVSI (OR = 4.222), Ktrans (OR = 25.243), adiponectin (OR = 0.756), and TNF-α (OR = 1.172) remained independent predictors (all P < 0.001). With an AUC of 0.933 in the training set, the nomogram incorporating MRI parameters and adipokines achieved 84.1% sensitivity and 93.2% specificity, while maintaining robust performance in the external validation set (sensitivity 89.3%, specificity 80.2%, AUC of 0.931), with good calibration and net clinical benefit. Conclusion The MRI–adipokine integrated nomogram uses only preoperative imaging and serum inputs and is intended for postoperative recurrence risk stratification after primary surgery. LVSI was retained only in the explanatory model and was not included in the final nomogram. The model showed promising discrimination and temporal reproducibility within a single-institution temporal cohort and may inform surveillance planning after independent multicenter validation; it is not yet ready for routine clinical use or for adjuvant therapy decisions.
Language: English
Field: Medicine
Open Access status: gold
Estimated APC paid: $1,400
OpenAlex ID: W7233565274
FWCI:
Cites: 31
Cited by:
Related to: